TR200806301A2 - Solubility and stability enhancing pharmaceutical formulation. - Google Patents
Solubility and stability enhancing pharmaceutical formulation.Info
- Publication number
- TR200806301A2 TR200806301A2 TR2008/06301A TR200806301A TR200806301A2 TR 200806301 A2 TR200806301 A2 TR 200806301A2 TR 2008/06301 A TR2008/06301 A TR 2008/06301A TR 200806301 A TR200806301 A TR 200806301A TR 200806301 A2 TR200806301 A2 TR 200806301A2
- Authority
- TR
- Turkey
- Prior art keywords
- solubility
- pharmaceutical formulation
- stability enhancing
- enhancing pharmaceutical
- stability
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002708 enhancing effect Effects 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş, çözünürlük sorunu olan bir aktif maddeyi stabilite sorunu olan bir terapötik ajanla kombinasyon halinde içeren farmasötik formülasyonlara, bunların hazırlanma yöntemlerine ve tıbbi kullanımlarına ilişkindir.The present invention relates to pharmaceutical formulations, methods of preparation and medical uses comprising an active substance having a solubility problem in combination with a therapeutic agent having a stability problem.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2008/06301A TR200806301A2 (en) | 2008-08-22 | 2008-08-22 | Solubility and stability enhancing pharmaceutical formulation. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2008/06301A TR200806301A2 (en) | 2008-08-22 | 2008-08-22 | Solubility and stability enhancing pharmaceutical formulation. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200806301A2 true TR200806301A2 (en) | 2010-03-22 |
Family
ID=42794718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2008/06301A TR200806301A2 (en) | 2008-08-22 | 2008-08-22 | Solubility and stability enhancing pharmaceutical formulation. |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR200806301A2 (en) |
-
2008
- 2008-08-22 TR TR2008/06301A patent/TR200806301A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200806298A2 (en) | Pharmaceutical formulation | |
| CY1119616T1 (en) | HUMAN ANTI-DUMP DRUG CONSUMPTION AGAINST TISSUE | |
| TR201809514T4 (en) | Long-term insulin formulations. | |
| ECSP109917A (en) | NEW DERIVATIVES OF AZABIFENILAMINOBENZOIC ACID | |
| CY2017018I2 (en) | PREPARATION OF ACTIVE, HIGHLY PHOSPHORYLATED, HUMAN LYSOSOMIC SULFATASE ENZYMES AND USES THEREOF | |
| ATE471144T1 (en) | INTRANASAL ADMINISTRATION OF RAPID-ACTING INSULIN | |
| EA201201050A1 (en) | PYRAZOLES AS AN ANTAGONISTS CRTH2 | |
| EA201390799A1 (en) | TRIAZOLOPRYRIDINS | |
| CY1117174T1 (en) | USE OF 24-norUDCA FOR TREATMENT OF US CHOLOGICAL DISEASES | |
| CY1109537T1 (en) | Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION | |
| CY1115961T1 (en) | ORVEPITANT MALEATE ANHYDRATED FORM OF CRYSTAL MALINE | |
| MX2009012782A (en) | Formulations for the oral administration of therapeutic agents and related methods. | |
| PT2459153E (en) | Pharmaceutical or cosmetic or dietetic composition for promoting a hair pigmentation effect | |
| WO2011002422A3 (en) | Solubility enhancing pharmaceutical formulation | |
| UY31839A (en) | COMPOUNDS | |
| TR200806300A2 (en) | Solubility enhancing pharmaceutical formulation | |
| TR200900879A2 (en) | Pharmaceutical compositions in which the active ingredients are combined in a single dosage form | |
| MX2010008365A (en) | Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers. | |
| JP2009292763A5 (en) | ||
| TR200806302A2 (en) | Solubility and stability enhancing pharmaceutical formulation. | |
| TR201803451T4 (en) | OLMESARTAN FORMULATIONS. | |
| IN2014DN10134A (en) | ||
| TR200806301A2 (en) | Solubility and stability enhancing pharmaceutical formulation. | |
| TR200806303A2 (en) | Pharmaceutical formulation to increase solubility and stability | |
| TR200806299A2 (en) | Solubility enhancing pharmaceutical formulation |